Podoplanin‐expressing inflammatory macrophages activate murine platelets via CLEC‐2
- 1 March 2012
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 10 (3), 484-486
- https://doi.org/10.1111/j.1538-7836.2011.04614.x
Abstract
No abstract availableFunding Information
- British Heart Foundation
- Ministerio de Educación, Cultura y Deporte (EX2009‐0242)
- Wellcome Trust
This publication has 12 references indexed in Scilit:
- CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for developmentBlood, 2012
- Novel platelet activation receptor CLEC‐2: from discovery to prospectsJournal of Thrombosis and Haemostasis, 2011
- Essential in Vivo Roles of the C-type Lectin Receptor CLEC-2: EMBRYONIC/NEONATAL LETHALITY OF CLEC-2-DEFICIENT MICE BY BLOOD/LYMPHATIC MISCONNECTIONS AND IMPAIRED THROMBUS FORMATION OF CLEC-2-DEFICIENT PLATELETSPublished by Elsevier BV ,2010
- Platelets regulate lymphatic vascular development through CLEC-2–SLP-76 signalingBlood, 2010
- GPVI and CLEC‐2 in hemostasis and vascular integrityJournal of Thrombosis and Haemostasis, 2010
- CLEC-2 Is a Phagocytic Activation Receptor Expressed on Murine Peripheral Blood NeutrophilsThe Journal of Immunology, 2009
- Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligandEuropean Journal of Immunology, 2008
- Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transitionJournal of Cell Science, 2006
- Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeletonCancer Cell, 2006
- A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2Blood, 2006